Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HPK1 INHIBITOR AND MEDICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/237085
Kind Code:
A1
Abstract:
The present invention relates to a compound represented by general formula (I), a stereoisomer, a tautomer, a deuterated compound or a pharmaceutically acceptable salt thereof, which has therapeutic activity against cancer. The present invention also relates to a method for preparing the compounds and a pharmaceutical composition containing same.

Inventors:
WU HAO (CN)
WU WENMAO (CN)
ZHANG ZHAN (CN)
XU YANJIE (CN)
YUAN DING (CN)
LU LU (CN)
WANG WEI (CN)
ZHU XIAOGUAN (CN)
ZHANG YONG (CN)
ZHANG JIAN (CN)
LIU XIANGLAI (CN)
ZHOU BOJUN (CN)
ZHOU QUAN (CN)
LAN HONG (CN)
WANG JIABING (CN)
DING LIEMING (CN)
Application Number:
PCT/CN2023/099307
Publication Date:
December 14, 2023
Filing Date:
June 09, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BETTA PHARMACEUTICALS CO LTD (CN)
International Classes:
A61K31/4035; C07D471/04; A61P35/04; C07D209/44
Domestic Patent References:
WO2021050964A12021-03-18
WO2019164847A12019-08-29
Foreign References:
US20050026976A12005-02-03
CN109721620A2019-05-07
Download PDF: